Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
about
Orlistat for the management of overweight individuals and obesity: a review of potential for the 60-mg, over-the-counter dosage.Changes on the physiological lactonase activity of serum paraoxonase 1 by a diet intervention for weight loss in healthy overweight and obese women.Orlistat: current status in clinical therapeutics.
P2860
Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Short-term administration of o ...... n with the metabolic syndrome.
@en
Short-term administration of o ...... n with the metabolic syndrome.
@nl
type
label
Short-term administration of o ...... n with the metabolic syndrome.
@en
Short-term administration of o ...... n with the metabolic syndrome.
@nl
prefLabel
Short-term administration of o ...... n with the metabolic syndrome.
@en
Short-term administration of o ...... n with the metabolic syndrome.
@nl
P2093
P2860
P356
P1433
P1476
Short-term administration of o ...... n with the metabolic syndrome.
@en
P2093
Gerasimos Krassas
Konstantinos Tziomalos
Martha Samara
Themistoklis Tzotzas
Theodoros Constantinidis
P2860
P356
10.1177/0003319706297915
P577
2007-02-01T00:00:00Z